Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page
- Check2 days agoChange DetectedThe page revision identifier was incremented from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the trial study details.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was rolled out, replacing the previous v3.4.3 release. The update appears to be a routine site version upgrade with no visible changes to the study details or functionality on this page.SummaryDifference0.1%

- Check45 days agoChange DetectedVersion bumped from v3.4.2 to v3.4.3 on the site.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1; no changes to core study content or functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.